Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 USD | +3.01% | -5.64% | -2.97% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Proprietary Medicinal Products
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howard Berman
CEO | Chief Executive Officer | 50 | 19-12-31 |
Fred Grossman
PSD | President | 62 | 23-07-16 |
David Snyder
DFI | Director of Finance/CFO | 63 | 22-03-29 |
Michelle Frazier
LAW | General Counsel | - | 23-06-13 |
Arun Swaminathan
PRN | Corporate Officer/Principal | - | 23-03-26 |
John M. Centanni
LAW | General Counsel | - | 22-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wilbur Ross
BRD | Director/Board Member | 85 | Dec. 18 |
Dov Goldstein
BRD | Director/Board Member | 56 | 21-04-13 |
Hideki Garren
BRD | Director/Board Member | 60 | 21-05-31 |
Dieter Weinand
BRD | Director/Board Member | 63 | 23-08-17 |
Director/Board Member | 65 | 21-05-24 | |
Ann Lee
BRD | Director/Board Member | 62 | 21-05-31 |
Howard Berman
CEO | Chief Executive Officer | 50 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,618,172 | 12,966,956 ( 88.70 %) | 0 | 88.70 % |
Company contact information
Coya Therapeutics, Inc.
5850 San Felipe Street Suite 500
77057, Houston
+
http://www.coyatherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.97% | 109M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- COYA Stock
- Company Coya Therapeutics, Inc.